Childhood Cancer

You are here

Acute Myelogenous Leukemia (AML)

Childhood acute myelogenous leukemia (AML) is a cancer of the myeloid cells that form white blood cells, red blood cells or platelets. AML is the second most common form of childhood leukemia. 

Latest Acute Myelogenous Leukemia (AML) grants

Margaret Ferris, MD/PhD, Principal Investigator
Washington University
Young Investigator Grants, Awarded 2019
Miriam Kim, MD, Principal Investigator
Washington University
Young Investigator Grants, Awarded 2019
Feng Pan, PhD, Principal Investigator
The Board of Trustees of the Leland Stanford Junior University
Young Investigator Grants, Awarded 2019

Latest Acute Myelogenous Leukemia (AML) blog posts

Every day, everywhere, children are diagnosed with cancer. Right now, children are in hospitals receiving frontline treatment following a diagnosis. Other children are beginning a clinical trial following a relapse. Still others face long-... more
Last year, we shared the story of 14-year-old Eden Green, who loves to take photos and dance. Eden was in treatment for a form of childhood cancer so rare, that doctors did not have a clinical name for it. After 4 months of treatment on a... more
Every day, around the world, over 700 children are diagnosed with one of the hundreds of types of childhood cancer—the equivalent of an entire elementary school of children. 

And everyday, researchers, powered by Alex's Lemonade Stand... more